technetium-tc-99m-exametazime and Barotrauma

technetium-tc-99m-exametazime has been researched along with Barotrauma* in 1 studies

Other Studies

1 other study(ies) available for technetium-tc-99m-exametazime and Barotrauma

ArticleYear
99Tcm-HMPAO single photon emission tomography in the diagnosis of cerebral barotrauma.
    The British journal of radiology, 1988, Volume: 61, Issue:732

    Cerebral barotrauma, or the neurological manifestation of the "bends", is a relatively common disease of divers and aviators. To date, however, no-one has succeeded in demonstrating a cerebral or spinal cord lesion in vivo following a decompression incident, despite the presence of definitive clinical signs and symptoms of central nervous system involvement. This paper describes the use of 99Tcm-labelled hexamethylpropyleneamine oxime (99Tcm-HMPAO) with single photon emission tomography in a study of three individuals involved in driving accidents. All three suffered cerebral barotrauma during decompression and all exhibited clinical signs and symptoms of dysbarism to a varying degree. Imaging was performed at time intervals ranging from 2 h to several days following the incidents. The results showed well defined cerebral ischaemic lesions in all three subjects. We conclude that 99Tcm-HMPAO imaging provides a significant advance in locating and demonstrating cerebral lesions following barotrauma and will contribute greatly to our understanding of the pathophysiological processes involved.

    Topics: Adolescent; Adult; Barotrauma; Brain Injuries; Brain Ischemia; Embolism, Air; Humans; Intracranial Embolism and Thrombosis; Male; Organometallic Compounds; Oximes; Technetium; Technetium Tc 99m Exametazime; Tomography, Emission-Computed

1988